• Vaginal infections: clinical significance and treatment

Vaginal infections: clinical significance and treatment

HEALTH OF WOMAN. 2018.4(130):19–22

Kisina V. I.
Sechenov First MSMU
Published: «Effektivnaya farmakoterapiya. Dermatovenerologiya i dermatokosmetologiya». 2011. No.1.


1. Larsen В. Microbiology of the female genital tract. Obstetric and Gynecologic infections Diseases. J. Pastorek (ed.). New York: Raven Press, 1994. P. 11–26.

2. Eschenbach DA, Davick PR, Willams DL et al. 1989. Prevalence of hydroden peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27:251–256.

3. Meads PB. 1993. Tpidermiology of bacterial vaginosis. Am.J. Obstet. Gynecol. 169:446–449. https://doi.org/10.1016/0002-9378(93)90338-J

4. Schmidt H, Hansen JG. 2000. Bacterial vaginosis in a family practice population. Acta Obstet. Gynecol. Scand. 79:999–1005. https://doi.org/10.1034/j.1600-0412.2000.079011999.x; https://doi.org/10.3109/00016340009169249; PMid:11081687

5. Schwebke JR, Morgan SC, Weiss HL. 1997. The use of sequential selfobtained vaginal smears for detecting changes in the vaginal flora. Sex Transm. Dis. 24:236–239. https://doi.org/10.1097/00007435-199704000-00009; PMid:9101636

6. Burbone F, Louv WC, Alexander WJ. 1990. A followup study of methods of contraception, sexual activity, and rates of trichomoniasis, and bacterial vaginosis. Am.J. Obster. Gynecol. 163:510–514. https://doi.org/10.1016/0002-9378(90)91186-G

7. Avonts D, Sercu M, Heyerick P et al. 1990. Incidence of uncomplicated genital infections in women using and contraception or an intrauterine device a prospective study. Sex Transm. Dis. 17:23–29. https://doi.org/10.1097/00007435-199017010-00006; PMid:2305333

8. Hawes SE, Hiller SL, Benedeni J et al. 1996. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174:1058–1063. https://doi.org/10.1093/infdis/174.5.1058; PMid:8896509

9. Hiller SL, Nugent RP, Eschenbach DA et al. 1995. Asociation between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N. Engl. J. Med. 333:1737–1742. https://doi.org/10.1056/NEJM199512283332604; PMid:7491137

10. Soper DE, Bump RC, Hurt WG. 1990. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectory. Am.J. Obstet. Gynecol. 163:1016–1021. https://doi.org/10.1016/0002-9378(90)91115-S

11. Penney GC, Thompson M, Norman J et al. 1998. A randomized comparison of strategies for reducing infective complications of induced abortion. Br.J. Obstet. Gynaecol. 105:599–604. https://doi.org/10.1111/j.1471-0528.1998.tb10173.x; PMid:9647149

12. Dokazatelnaya meditsina: ezhegodnyiy mezhdunarodnyiy spravochnik. per. s angl. 2; 5. M, Media Sfera. 2003.

13. Sobel JD, Faro S, Force RW et al. 1998. Vulvovaginal candidiasis epidemiologic, diagnostic, and therapeutic considerations. Am.J. Obstet. Cynecol. 178:203–211. https://doi.org/10.1016/S0002-9378(98)80001-X

14. Sobel JD. 1999. Vulvovaginal candidiasis. Sexually transmitted diseases. R.R. Holmes et al. (eds.). 3rd ed. N-Y: McGraw-Hill. P. 629–639.

15. Sobel JD. 2003. Management of patients with recurrent vulvovaginal candidiasis. Drugs. 63:1059–1066. https://doi.org/10.2165/00003495-200363110-00002; PMid:12749733

16. Foxman B. 1990. The epidemiology of vulvovaginal candidiasis risk factors II. Am.J. Public. Health 80:329–321. https://doi.org/10.2105/AJPH.80.3.329; PMid:2305918 PMCid:PMC1404680

17. Geiger AM, Foxman В, Sobel JD. 1995. Chronic vulvovaginal candidiasis characteristics of women with Candida albicans, C. glabrata and no Candida. Genitourin Med. 71:304–307.

18. Geiger AM, Foxman В, Gillespie BM. 1995. The epidemiology of vulvovaginal candidiasis among university students. Am.L. Public. Health. 85:1146–1148. https://doi.org/10.2105/AJPH.85.8_Pt_1.1146

19. Dokazatelnaya meditsina: ezhegodnyiy mezhdunarodnyiy spravochnik. per. s angl. 2; 4. M, Media Sfera. 2003.

20. Duerr A, Heilig С, Meikle S et al. 2003. Incident and persistent vulvovaginal candidiasis among human immunodeficiency virusinfected women: risk factors and severity. Obstet. Gynecol. 101:548–556. https://doi.org/10.1016/S0029-7844(02)02729-1; https://doi.org/10.1097/00006250-200303000-00022; PMid:12636961

21. McClelland R, Lavreys L, Katingima C et al. 2005. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J. Infect. Dis. 191:333–338. https://doi.org/10.1086/427262; PMid:15633091

22. Petersen EE, Magnani P. 2004. Efficacy and safety of vitamin С vaginal tablets in the treatment of non-specific vaginitis; a randomized, double blind, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 117:70–75. https://doi.org/10.1016/j.ejogrb.2004.02.032; PMid:15474248

23. Hickson M, D’Souza AL, Muthu N et al. 2007. Use of probiotic Lactobacillus preparation to prevent diarrhea associated with antibiotics: randomized double blind placebo controlled trial. BMJ. 335:80.

24. D’Souza AL. 2002. Probiotics in prevention of antibiotic associated diarrhea: meta-analysis. BMJ. 324:1361.